Cargando…

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice

Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of chronic liver disease. NAFLD begins with excessive lipid accumulation in the liver and progresses to nonalcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is closely linked to dysregulated hepatic lipid metabolism. Although re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choung, Sorim, Kim, Ji Min, Joung, Kyong Hye, Lee, Eaum Seok, Kim, Hyun Jin, Ku, Bon Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368280/ https://www.ncbi.nlm.nih.gov/pubmed/30735525 http://dx.doi.org/10.1371/journal.pone.0210828

Ejemplares similares

Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
por: Choung, Sorim, et al.
Publicado: (2018)

Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018)

Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study
por: Joung, Kyong Hye, et al.
Publicado: (2020)

Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus
por: Kim, Ji Min, et al.
Publicado: (2021)

Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals
por: Joung, Kyong Hye, et al.
Publicado: (2018)

Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
por: Lee, Jun Choul, et al.
Publicado: (2014)

Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma
por: Rou, Woo Sun, et al.
Publicado: (2023)

The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus
por: Kang, Yea Eun, et al.
Publicado: (2017)

Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity
por: Lee, Eaum Seok, et al.
Publicado: (2017)

Serum CD14 concentration is associated with obesity and insulin resistance in non-diabetic individuals
por: Kang, Yea Eun, et al.
Publicado: (2022)

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014)

Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance
por: Kang, Yea Eun, et al.
Publicado: (2019)

The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms
por: Joung, Kyong Hye, et al.
Publicado: (2015)

Barley Sprouts Extract Attenuates Alcoholic Fatty Liver Injury in Mice by Reducing Inflammatory Response
por: Lee, Yun-Hee, et al.
Publicado: (2016)

A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2017)

Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity
por: Kim, Seok-hyung, et al.
Publicado: (2020)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

Serum MIG6 concentration is increased by cholesterol-lowering treatment in patients with type 2 diabetes mellitus and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults
por: Lee, Inhwan, et al.
Publicado: (2020)

A Novel PHEX Gene Mutation in a Patient with Sporadic Hypophosphatemic Rickets
por: Kang, Yea Eun, et al.
Publicado: (2014)

Plasma Adiponectin Levels in Elderly Patients with Prediabetes
por: Kong, Si Eun, et al.
Publicado: (2015)

Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease
por: Si, Jiyeon, et al.
Publicado: (2021)

The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction
por: Kang, Yea Eun, et al.
Publicado: (2016)

Lonicera caerulea Extract Attenuates Non-Alcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Hepatocytes and in High Fat Diet-Fed Mice
por: Park, Miey, et al.
Publicado: (2019)

Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease
por: Pei, Erli, et al.
Publicado: (2018)

Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver disease
por: Lee, Yun-Hee, et al.
Publicado: (2016)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
por: Yoon, Sang Jun, et al.
Publicado: (2023)

Terminalia paniculata bark extract attenuates non-alcoholic fatty liver via down regulation of fatty acid synthase in high fat diet-fed obese rats
por: Ramgopal, Mopuri, et al.
Publicado: (2014)

A Nomogram for Predicting Non-Alcoholic Fatty Liver Disease in Obese Children
por: Kim, Ahlee, et al.
Publicado: (2020)

Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity
por: Kim, Ju Young, et al.
Publicado: (2018)

Loss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease
por: Huang, Chao, et al.
Publicado: (2022)

Changes in the Prevalences of Obesity, Abdominal Obesity, and Non-Alcoholic Fatty Liver Disease among Korean Children during the COVID-19 Outbreak
por: Song, Kyungchul, et al.
Publicado: (2023)

Can Zinc Supplementation Attenuate High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease?
por: Bolatimi, Oluwanifemi Esther, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
por: Félix, Deise Rosa, et al.
Publicado: (2016)

Can Diet Help Non-Obese Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)?
por: Merchant, Hamid A.
Publicado: (2017)

Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling
por: Kim, Mi Hye, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed Rats
por: Park, Eun-Jung, et al.
Publicado: (2020)

Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model
por: Li, Hua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_si3h6p2t644oooks481ngpiral